Protalix Company
Protalix is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Its pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets.
Founded Date:
1993
Investor Type:
N/A
Employee Number:
200-500
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Technology:
Biotechnology, Pharmaceutical, Therapeutics
Industry:
Personalized Medicine
Headquarters:
Carmiel, Israel